CN109118253A - Block chain drug management-control method, device, medium and electronic equipment - Google Patents
Block chain drug management-control method, device, medium and electronic equipment Download PDFInfo
- Publication number
- CN109118253A CN109118253A CN201810960721.5A CN201810960721A CN109118253A CN 109118253 A CN109118253 A CN 109118253A CN 201810960721 A CN201810960721 A CN 201810960721A CN 109118253 A CN109118253 A CN 109118253A
- Authority
- CN
- China
- Prior art keywords
- drug
- information
- block chain
- risk class
- risk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/018—Certifying business or products
- G06Q30/0185—Product, service or business identity fraud
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
Landscapes
- Business, Economics & Management (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Accounting & Taxation (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Entrepreneurship & Innovation (AREA)
- Medicinal Chemistry (AREA)
- Development Economics (AREA)
- Economics (AREA)
- Finance (AREA)
- Marketing (AREA)
- Strategic Management (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The present embodiments relate to block chain technical fields, provide a kind of block chain drug management-control method, device, computer-readable medium and electronic equipment, which includes: to construct block chain network according to carrying out multiple information nodes that whole process tracks to drug；Based on negative sense feedback check method to the potential risk of the multiple information node automatic identification drug in the block chain network, risk class is obtained；If identifying that the drug reaches prompting rule in the risk class that any link occurs, prompting message is generated.The technical solution of the embodiment of the present invention can all upload to block chain by the data of each information node for generating the tracking of drug whole process, to according to the secret protection of the relevant informations such as the drug whole process tracking of block chain storage, can be traced, be not easy the features such as distorting.
Description
Technical field
The present invention relates to block chain technical fields, in particular to a kind of block chain drug management-control method, device, Jie
Matter and electronic equipment.
Background technique
Problems are faced in medical product circulation at present, such as: fake and forged, expired, failure.The circulation of drug
Distribution network is extremely complex, and drug is before eventually arriving at consumer, in addition to the production phase, also tends to need by distribution, pin
It sells etc. and to change hands for several times.The distribution distribution network of this clock complexity leaves to fake producer to have an opportunity to take advantage of, meanwhile, many and diverse intermediate links produce
Raw cost and adverse consequences is directly passed on to consumers.Fake and forged drug can not only bring the damage of each side economically
It loses, it is also possible to patient be caused to miss best occasion for the treatment even life danger.
Based on the foregoing, it is desirable to control quality of the medical product in supply chain, in general, drug distributes information
It is to be collected from list of medications and doctor formula.In some markets, pharmacy does not retain detailed real-time electronic inventory or disease
People does not have prescription but periodically buys drug, is difficult or impossible to collect accurately distribution information in this way.
Therefore, there is also the places that has much room for improvement in technical solution in the prior art.
It should be noted that information is only used for reinforcing the reason to background of the invention disclosed in above-mentioned background technology part
Solution, therefore may include the information not constituted to the prior art known to persons of ordinary skill in the art.
Summary of the invention
The embodiment of the present invention is designed to provide a kind of block chain drug management-control method, device, medium and electronic equipment,
And then the shortcomings that overcoming the low efficiency of existing method for processing video frequency at least to a certain extent.
Other characteristics and advantages of the invention will be apparent from by the following detailed description, or partially by the present invention
Practice and acquistion.
According to a first aspect of the embodiments of the present invention, a kind of block chain drug management-control method is provided, comprising:
Block chain network is constructed according to multiple information nodes that whole process tracks are carried out to drug；
Based on negative sense feedback check method to the multiple information node automatic identification drug in the block chain network
Potential risk, obtain risk class；
If identifying that the drug reaches prompting rule in the risk class that any link occurs, prompting letter is generated
Breath.
In some embodiments of the invention, the data of the information node include time data, locality data and confirmation
Data, the multiple information node include at least production information, transit information, check information, sales information, use information and throwing
Tell one of information.
In some embodiments of the invention, the information node is stored with linked data structure, and building forms institute
State block chain network；
Wherein the linked data structure includes: nomenclature of drug, drug batch number, due date, handler's public-key cryptography, visits
Ask public-key cryptography, the handler's signature, the data of information node, the link of the storage address of similar drug historical record data of personnel
And prompting message.
In some embodiments of the invention, to the data of the information node, the similar drug historical record data
Storage address link and the prompting message by Hash pointer link in the form of store.
In some embodiments of the invention, the multiple information node in the block chain network is directed to different groups
And different access authority is set separately in the subsidiary under group.
In some embodiments of the invention, based on negative sense feedback check method to described more in the block chain network
A information node automatic identification drug potential risk, obtaining risk class includes:
Virtual condition information based on the multiple information node feedback carries out that quality score is calculated；
The grade classification that potential risk is carried out according to the quality score, obtains risk class, wherein the risk class
It include: safe, dangerous and emphasis supervision.
In some embodiments of the invention, the virtual condition information based on the multiple information node feedback is calculated
Obtaining quality score includes:
The virtual condition information that the drug is fed back in each market is obtained, wherein the virtual condition packet
Include the data of each information node；
It is calculated in the drug according to the virtual condition information in quality score locality, wherein described be locality
One of described market；
Calculation formula are as follows:
Wherein YnIt is the drug in n-th of quality score locality, n is the positive integer of 1~N, and N is indicated locality
Number, An are the drug in n-th of sales volume locality, and m is the positive integer of 1~M, and M indicates the number of sales territory, N
≤ M, a and b are coefficient, XmVirtual condition information for the drug m-th of market.
In some embodiments of the invention, based on negative sense feedback check method to described more in the block chain network
A information node automatic identification drug potential risk, obtaining risk class includes:
If being included in a certain market in the calling information of the drug has a plurality of negative complaint, the risk class
For emphasis supervision.
In some embodiments of the invention, based on negative sense feedback check method to described more in the block chain network
A information node automatic identification drug potential risk, obtaining risk class includes:
If the market of the drug is using ground for the drug in the first area, but in the use information
Second area, and the spacing between first area and second area is more than preset range, then the risk class is
Emphasis supervision, object of supervision are bizonal drug；And/or
If the market of the drug is using ground for the drug in the first area, but in the use information
Multiple territory of use, and the multiple area is all different with first area, then the risk class is emphasis supervision, prison
Examine the drug that object is the multiple territory of use.
According to a second aspect of the embodiments of the present invention, a kind of block chain drug control device is provided, comprising:
Node tracking module obtains multiple information nodes for carrying out whole process tracking to drug；
Network struction module, for constructing block chain network according to multiple information nodes；
Network struction module, for carrying out multiple information nodes building block chain that whole process tracks according to drug
Network；
Risk identification module, for based on negative sense feedback check method to the multiple information in the block chain network
The potential risk of node automatic identification drug, obtains risk class；
Warning module, if for identifying that the drug reaches prompting rule in the risk class that any link occurs,
Then generate prompting message.
According to a third aspect of the embodiments of the present invention, a kind of computer-readable medium is provided, computer is stored thereon with
Program realizes the block chain drug management-control method as described in first aspect in above-described embodiment when described program is executed by processor
The step of.
According to a fourth aspect of the embodiments of the present invention, a kind of electronic equipment is provided, comprising: one or more processors；
Storage device, for storing one or more programs, when one or more of programs are held by one or more of processors
When row, so that one or more of processors realize the block chain drug control side as described in first aspect in above-described embodiment
Method.
Technical solution provided in an embodiment of the present invention can include the following benefits:
In the technical solution provided by some embodiments of the present invention, on the one hand, produced by tracking drug whole process
The data of raw each information node all upload to block chain, thus according to correlations such as the drug whole process tracking of block chain storage
The secret protection of information can be traced, be not easy the features such as distorting.On the other hand, pass through the data of each information node to feedback
Risk Calculation and assessment are carried out, remind the potential fake production of medicine of drug control institutions in time and reminds the potential risk management of client (false
Emit, the shelf-life expires) etc., to effectively promote block chain technical application in effective popularization of the anti-fraud management aspect of drug.
It should be understood that above general description and following detailed description be only it is exemplary and explanatory, not
It can the limitation present invention.
Detailed description of the invention
The drawings herein are incorporated into the specification and forms part of this specification, and shows and meets implementation of the invention
Example, and be used to explain the principle of the present invention together with specification.It should be evident that the accompanying drawings in the following description is only the present invention
Some embodiments for those of ordinary skill in the art without creative efforts, can also basis
These attached drawings obtain other attached drawings.In the accompanying drawings:
Fig. 1 shows the flow diagram of the block chain drug management-control method of embodiment according to the present invention；
Fig. 2 shows the flow diagrams of step S103 in embodiment according to the present invention Fig. 1；
Fig. 3 shows the flow diagram of step S201 in embodiment according to the present invention Fig. 2；
Fig. 4 shows the structural schematic diagram of the block chain drug control device of embodiment according to the present invention；
Fig. 5 shows the composition schematic diagram of the block chain drug managing and control system of embodiment according to the present invention；
Fig. 6 shows the structural schematic diagram for being suitable for the computer system for the electronic equipment for being used to realize the embodiment of the present invention.
Specific embodiment
Example embodiment is described more fully with reference to the drawings.However, example embodiment can be with a variety of shapes
Formula is implemented, and is not understood as limited to example set forth herein；On the contrary, thesing embodiments are provided so that the present invention will more
Fully and completely, and by the design of example embodiment comprehensively it is communicated to those skilled in the art.
In addition, described feature, structure or characteristic can be incorporated in one or more implementations in any suitable manner
In example.In the following description, many details are provided to provide and fully understand to the embodiment of the present invention.However,
It will be appreciated by persons skilled in the art that technical solution of the present invention can be practiced without one or more in specific detail,
Or it can be using other methods, constituent element, device, step etc..In other cases, it is not shown in detail or describes known side
Method, device, realization or operation are to avoid fuzzy each aspect of the present invention.
Block diagram shown in the drawings is only functional entity, not necessarily must be corresponding with physically separate entity.
I.e., it is possible to realize these functional entitys using software form, or realized in one or more hardware modules or integrated circuit
These functional entitys, or these functional entitys are realized in heterogeneous networks and/or processor device and/or microcontroller device.
Flow chart shown in the drawings is merely illustrative, it is not necessary to including all content and operation/step,
It is not required to execute by described sequence.For example, some operation/steps can also decompose, and some operation/steps can close
And or part merge, therefore the sequence actually executed is possible to change according to the actual situation.
Fig. 1 shows the flow diagram of the block chain drug management-control method of embodiment according to the present invention, with reference to Fig. 1,
The block chain drug management-control method includes:
Step S101 constructs block chain network according to multiple information nodes that whole process tracks are carried out to drug.
Step S102, it is automatic to the multiple information node in the block chain network based on negative sense feedback check method
The potential risk for identifying drug, obtains risk class.
Step S103 is produced if identifying that the drug reaches prompting rule in the risk class that any link occurs
Raw prompting message.
In technical solution provided by embodiment shown in Fig. 1, on the one hand, each by generating the tracking of drug whole process
The data of a information node all upload to block chain, thus according to relevant informations such as the drug whole process tracking of block chain storage
Secret protection can be traced, be not easy the features such as distorting.On the other hand, wind is carried out by the data of each information node to feedback
Danger calculates and assessment, reminds the potential fake production of medicine of drug control institutions in time and reminds the potential risk management of client that (personation, guarantees the quality
Phase expires) etc., to effectively promote block chain technical application in effective popularization of the anti-fraud management aspect of drug.
The specific implementation of each step of embodiment illustrated in fig. 1 is described in detail below:
In step s101, multiple information nodes building block link network that whole process tracks is carried out according to drug
Network.
In some embodiments of the invention, whole process tracking is related to the production of drug, transport, inspection, sale, uses
Links, correspondingly, the data of the information node include time data, locality data and confirmation data, the multiple letter
It ceases node and includes at least one of production information, transit information, inspection information, sales information, use information and calling information.
In some embodiments of the invention, the information node is stored with linked data structure, building is formed
The block chain network.
Table 1, which is shown based on the data structure mode of block chain technology, stores drug whole process tracing management relevant information
Example, the linked data structure include: nomenclature of drug, drug batch number, due date, handler's public-key cryptography, access personnel
Public-key cryptography, handler's signature, the data of information node, the storage address of similar drug historical record data link and remind
Information.
Table 1
As shown in table 1, wherein it is A, drug batch number XXX1, due date that the linked data structure, which includes: nomenclature of drug,
For 2019.1.10, privacy authorization be authorized/unauthorized, handler's public-key cryptography be ATCGWKY123YTU, access personnel
Public-key cryptography 1392929293346 mapping of account addresses (indicate arrive), handler are signed the data, same of XXXY, information node
The storage address of similar drug historical record data links and prompting message, the data of information node include the production of drug (time,
Place, confirmation), transport (time, place, confirmation), check (time, place, confirmation), sale (it is wholesale or retail: the time,
Point, confirmation), complain (time, place, confirmation), client to use the whole processes tracking information such as (time, place, confirmation).
Wherein, to the storage address link of the data of the information node, the similar drug historical record data and institute
It states prompting message to store in the form of the link of Hash pointer, data structure mode, the information storage means defined according to the present embodiment
Shared information etc. is stored and authenticates, with agreement to guarantee the high efficiency of information storage and information processing.
In some embodiments of the invention, can be using some branch of certain group as minimum node, one or
Multiple large size groups/companies' participation drug, which is instead faked, manages transaction block chain network building.
It should be noted that in some embodiments of the invention, the multiple information section in the block chain network
Different access authority, such as the access authority of setting group is set separately for the subsidiary under different groups and group in point
Rank highest can check the data of all information node, and the access authority rank of the subsidiary under group is taken second place, only can be with
It checks the data of the relevant partial information node of subsidiary's business, and arrives the access authority of some branch (such as department)
Rank is more lower.
For example, the swin flu vaccine of certain company production obtains listing license, the vaccine batch after the examination & approval of national Bureau of Drugs Supervision are qualified
Amount produces and lists transaction, and for secondary vaccine trading activity, block chain network can generate a new block, the input of block
It can be pharmaceutical production information { time=20180108, place=xx pharmaceutical factory, manufacturer's confirmation=yyy }, transit information
{ time=20180110, place=Shanghai-Beijing, supplier's confirmation=zzz }, detection information { time=20180108, approval and sign
Mechanism confirmation=AAA；Time=20180110, transport regulatory agency's confirmation=BBB, sale it is wholesale: time=20180110,
Place=xx Community Health Station, confirmation=CCC；..., complain { time=20180201, place=xx community sanitary clothes
Business station, confirmation=DDD；..., client use time=20180112, place=xx Community Health Station, confirmation=
VVV；... etc. the information such as whole processes tracking information, public-key cryptography=ATCGWKY123YTU of related personnel and signature=XXXY.
The storage links that the output of one transaction can be the associated documents material that drug whole process tracks (such as can be Hash pointer
Link), the public-key cryptography of fake production of medicine or the risk information prompting=lethality 13.13/10000ths that expires, relevant information visitor
(account address) etc..
All records open different groups/company's graduation, make full use of the secret protection of block chain information, can chase after
It traces back, be not easy the characteristics of distorting, transport process for using using historical information supervision pharmaceutical production to greatest extent, most believable medicine is provided
The anti-management service of faking of product.
In step s 102, based on negative sense feedback check method to the multiple information node in the block chain network
The potential risk of automatic identification drug, obtains risk class.
In some embodiments of the invention, the drug that negative sense feedback check method specifically refers to feed back based on negative sense is launched
And using the method for region and the random cross check of Annual distribution feature to the multiple information in the block chain network
Node is monitored.
For being fed back using negative calling information as negative sense, if then step S102 includes: the throwing of the drug
Tell that being included in a certain market in information has a plurality of negative complaint, then the risk class is emphasis supervision.
For example, certain drug A emphasis launch area and also negatively complain it is more, to the batch close to drug due date into
The strategies such as the probability increasing of row random inspection.
For launching and using region to feed back as negative sense using drug, then step S102 includes:
If the market of the drug is using ground for the drug in the first area, but in the use information
Second area, and the spacing between first area and second area is more than preset range, then the risk class is
Emphasis supervision, object of supervision are bizonal drug；And/or
If the market of the drug is using ground for the drug in the first area, but in the use information
Multiple territory of use, and the multiple area is all different with first area, then the risk class is emphasis supervision, prison
Examine the drug that object is the multiple territory of use.
For example, according to the historical data of the drug whole process tracking in block chain, system automatic identification is potentially faked medicine
Product, it is D1 that the drug A that certain lot number is XXX, which launches regional (market), but transaction results show that the drug A of the lot number appears in thousand
In except regional D2；Or certain lot number is the drug A of XXX, but transaction results show that the drug A of the lot number is appeared in multiplely
Area, then only one of them be it is genuine, the drug A in other areas there is be counterfeit drug risk.
For being fed back using Annual distribution feature as negative sense, then step S102 includes:
If when the selling time recorded in the sales information of the drug or the use recorded in the use information
Between compared with validity period of the drug, find the selling time or it is described the use of the time is more than the validity period, then
Risk class is dangerous.
For example, reminding the potential drug of drug control institutions to make for the drug of the dispensing close to drug due date, and in time
False and prompting potential risk management of client (personation, shelf-life expire) etc., to effectively promote block chain technical application in medicine
Effective popularization of the anti-fraud management aspect of product.
In step s 103, if identifying that the drug reaches prompting rule in the risk class that any link occurs,
Then generate prompting message.
Any link may be production, transport, inspection, sale, any one of use link, as long as wherein one
A link goes wrong, it is possible to will cause counterfeit drug into user hand, it is therefore necessary to strict inspection links.
Prompting rule therein is that risk class is emphasis supervision or unsafe just prompting, and only risk class is safety
Ability without remind.
In some embodiments of the invention, if Fig. 2 shows step S103 automatic identification to the drug in any ring
The risk class of section reaches prompting rule, then the flow diagram of prompting message is generated, with reference to Fig. 2, comprising:
Step S201, the virtual condition information based on the multiple information node feedback carry out that quality score is calculated,
Wherein the specific steps of the step are shown in following Fig. 3.
Step S202 carries out the grade classification of potential risk according to the quality score, obtains risk class, wherein described
Risk class includes: safe, dangerous and emphasis supervises three grades.
The step rule of thumb and specifically can need to set the rule of grade classification, for example, quality score > 90 indicate
Drug safety, quality score < 60 indicate that there are quality problems, dangerous, other (i.e. 60≤quality score≤0) indicate peace at present
Entirely, but drug may face the phase, need to increase sampling observation dynamics.
In some embodiments of the invention, Fig. 3 shows the reality based on the multiple information node feedback in step S201
Border status information carries out the flow diagram that quality score is calculated, with reference to Fig. 3, comprising:
Step S301 obtains the virtual condition information that the drug is fed back in each market, wherein the reality
Status information includes the data of each information node；
Step S302 is calculated in the drug according to the virtual condition information in quality score locality, wherein institute
It states locality as one of described market.Calculation formula in the step are as follows:
Wherein YnIt is the drug in n-th of quality score locality, n is the positive integer of 1~N, and N is indicated locality
Number, An are the drug in n-th of sales volume locality, and m is the positive integer of 1~M, and M indicates the number of sales territory, N
≤ M, a and b are coefficient, XmVirtual condition information for the drug m-th of market.
For example, selling to Hebei, Henan, three, Shandong ground respectively after the hepatitis B vaccine listing of certain biological agent company S production
Area, all processes of this vaccine from producing to using upload to block chain, in subsequent vaccine follow-up service, discovery 2018
During 6-8 month in year, there is anaphylactoid user feedback after there is over one hundred vaccine due to injection S producer in the city M of Hebei province
(calling information fed back), much higher than other area adverse reaction probability of happening, according to the vaccine various regions total sales volume,
The city the INFORMATION DISCOVERYs M problem hepatitis B vaccines such as vaccine feedback information, whole process tracking historical data are all from P producer
Batch be 2018xxxxT hepatitis B vaccine, and the hepatitis B vaccine quantity of batch 2018xxxxT that the city M had been injected is big
The sale quantity shown in system, system conclude that the hepatitis B vaccine of the batch 2018xxxxT of P producer production is doubtful and deposit
Quality problems (personation or unqualified).Then drug control institutions potential risk is reminded according to prompt information and requests supervision department
It gets involved in the investigation.
Using this method to drug carry out timeliness, effectively and accurately control, based on negative sense feedback drug launch and
Using the availability of region and the method for the random cross check of Annual distribution feature, to by effective in block chain network
The counter management of faking of drug is realized, thus effectively effective popularization of the promotion block chain technical application in the anti-fraud management aspect of drug.
In conclusion using block chain drug management-control method provided in an embodiment of the present invention, on the one hand, by the way that drug is complete
The data for each information node that flow tracking generates all upload to block chain, thus the drug whole process stored according to block chain
The secret protections of relevant informations such as tracking can be traced, be not easy the features such as distorting.On the other hand, pass through each information to feedback
The data of node carry out Risk Calculation and assessment, remind the potential fake production of medicine of drug control institutions in time and remind the potential medicine of client
Product risk (personation, shelf-life expire) etc., to effectively promote block chain technical application in drug, anti-fraud management aspect has
Effect is promoted.
The device of the invention embodiment introduced below can be used for executing the above-mentioned block chain drug control side of the present invention
Method.
Fig. 4 shows the structural schematic diagram of the block chain drug control device of embodiment according to the present invention, with reference to Fig. 4,
Block chain drug control device 400, comprising: network struction module 401, risk identification module 402 and warning module 403.
Network struction module 401 is used to carry out multiple information nodes building block that whole process tracks according to drug
Chain network；Risk identification module 402 is used for based on negative sense feedback check method to the multiple letter in the block chain network
The potential risk for ceasing node automatic identification drug, obtains risk class；If warning module 403 is for identifying that the drug exists
The risk class that any link occurs reaches prompting rule, then generates prompting message.
Each functional module and above-mentioned block chain due to the block chain drug control device of example embodiments of the present invention
The step of example embodiment of drug management-control method, is corresponding, therefore for undisclosed details in apparatus of the present invention embodiment, asks
Referring to the embodiment of the above-mentioned block chain drug management-control method of the present invention.
The embodiment of the present invention also provides a kind of system suitable for above-mentioned block chain drug management-control method, and Fig. 5 shows this and is
The composition schematic diagram of system, as shown in figure 5, the system 500 includes: network struction subsystem 501, data format definition subsystem
502, information storage subsystem 503, anti-fraud management subsystem 504 and Performance Evaluation subsystem 505.
Wherein network struction subsystem 501 is used for using some branch of certain group as minimum node, one or more
Large-scale group/company's participation drug, which is instead faked, manages transaction block chain network building；Data format definition subsystem 502 is for pressing
Shared information etc. is stored and authenticates according to data structure mode, information storage means and the agreement of the invention defined, to guarantee to believe
The high efficiency of breath storage and information processing；Information storage subsystem 503 be used for by pharmaceutical production, transport, inspection, sale, complaint,
Client using etc. whole processes tracking information upload to block chain；Anti- fraud management subsystem 504 is used for the medicine fed back based on negative sense
Product are launched and the method for the random cross check using region and Annual distribution feature, according to the drug whole process in block chain with
The historical data of track, the drug of system automatic identification potentially fraud drug and the dispensing close to drug due date, and in time
Remind the potential fake production of medicine of drug control institutions and remind the potential risk management of client etc.；Performance Evaluation subsystem 505 is for commenting
Estimate the drug anti-timeliness of fraud management system, validity and accuracy, region is launched and used to the drug based on negative sense feedback
With the availability of the method for the random cross check of Annual distribution feature, to by effectively realizing drug in block chain network
Anti- management of faking.
Wherein information storage subsystem 503 by pharmaceutical production (time, place, confirmation), transport (time, place, confirmation),
It checks (time, place, confirmation), sale (wholesale or retail: time, place, confirmation), complain (time, place, confirmation), visitor
Family uses whole processes tracking informations such as (time, place, confirmations) to upload to block chain, for example, the swin flu vaccine of certain company production
Listing license is obtained after the examination & approval of national Bureau of Drugs Supervision are qualified, which produces and list transaction in batches, trades for secondary vaccine
Behavior, block catenary system can generate a new block, the input of block can be pharmaceutical production information the time=
20180108, place=xx pharmaceutical factory, manufacturer's confirmation=yyy }, transit information time=20180110, place=on
Sea-Beijing, supplier's confirmation=zzz }, detection information { time=20180108, approval and sign mechanism confirmation=AAA；Time=
20180110, transport regulatory agency's confirmation=BBB, sale it is { wholesale: time=20180110, place=xx urban community health services
It stands, confirmation=CCC；..., complain { time=20180201, place=xx Community Health Station, confirmation=DDD；...},
Client uses { time=20180112, place=xx Community Health Station, confirmation=VVV；... etc. whole processes tracking letter
The output of the information such as breath, public-key cryptography=ATCGWKY123YTU of related personnel and signature=XXXY, a transaction can be medicine
Storage links, fake production of medicine or the risk information prompting=lethality ten thousand that expires of the associated documents material of product whole process tracking/
13.13 (can set), public-key cryptography (account address) of relevant information visitor etc..All records are to different group/companies point
Grade is open, makes full use of the secret protection of block chain information, can be traced, be not easy the characteristics of distorting, and is believed to greatest extent using history
Process for using is transported in breath supervision pharmaceutical production, provides most believable drug anti-management service of faking.
The drug that anti-fraud management subsystem 504 is fed back based on negative sense launch and using region and Annual distribution feature with
The method of machine cross check is monitored the multiple information node in the block chain network.
For being fed back using negative calling information as negative sense, then if described in anti-fraud management subsystem 504
Being included in a certain market in the calling information of drug has a plurality of negative complaint, then the risk class is emphasis supervision.
For example, certain drug A emphasis launch area and also negatively complain it is more, to the batch close to drug due date into
The big equal strategies of the probability of row random inspection.
For launching and using region to feed back as negative sense using drug, then in anti-fraud management subsystem 504 such as
The market of drug described in fruit uses ground for the second area in the first area, but in the use information for the drug,
And the spacing between first area and second area is more than preset range, then the risk class is emphasis supervision,
Object of supervision is bizonal drug；And/or if the market of the drug in the first area, but in the use information
What it is for the drug is multiple territory of use with using, and the multiple area is all different with first area, then institute
Risk class is stated as emphasis supervision, object of supervision is the drug of the multiple territory of use.
For example, according to the historical data of the drug whole process tracking in block chain, system automatic identification is potentially faked medicine
Product (if it is D1 that the drug A that certain lot number is XXX, which launches area, but transaction results show the drug A of the lot number appear in a thousand li it
Outer regional D2；Or certain lot number is the drug A of XXX, but transaction results show that the drug A of the lot number appears in multiple areas,
So only one of them is genuine).
For being fed back using Annual distribution feature as negative sense, then if described in anti-fraud management subsystem 504
The selling time recorded in the sales information of drug or the having using time and the drug recorded in the use information
The effect phase compares, it is found that the selling time or the use time are more than the validity period, then risk class is dangerous.
For example, the drug of the dispensing close to drug due date, and remind in time the potential fake production of medicine of drug control institutions and
Potential risk management of client (personation, shelf-life expire) etc. is reminded, to effectively promote block chain technical application anti-in drug
Effective popularization of fraud management aspect.
Model in the system are as follows:
Wherein YnIt is the drug in n-th of quality score locality, n is the positive integer of 1~N, and N is indicated locality
Number, An are the drug in n-th of sales volume locality, and m is the positive integer of 1~M, and M indicates the number of sales territory, N
≤ M, a and b are coefficient, XmVirtual condition information for the drug m-th of market, such as negative complaint, production batch, throwing
Put quantity, due date etc..
For example, Hebei, Henan, three, Shandong ground are sold to respectively after the hepatitis B vaccine listing of certain biological agent company S production
Area, all processes of this vaccine from producing to using upload to block chain, in subsequent vaccine follow-up service, discovery 2018
During 6-8 month in year, there is anaphylactoid user feedback after there is over one hundred vaccine due to injection S producer in the city M of Hebei province,
Much higher than the adverse reaction probability of happening in other areas, our drug instead sell according to the vaccine in various regions by fraud management subsystem
The city the INFORMATION DISCOVERYs M problem hepatitis B vaccines such as total amount, vaccine feedback information, whole process tracking historical data are sold all to be from
The hepatitis B vaccine for being 2018xxxxT in the batch of P producer, and the hepatitis B vaccine of batch 2018xxxxT that the city M had been injected
Quantity is greater than the sale quantity shown in system, and system concludes that the hepatitis B vaccine of the batch 2018xxxxT of P producer production
It is doubtful that there are quality problems (personation or unqualified).Management system can remind drug control institutions potential risk simultaneously according to prompt information
Request supervision department gets involved in the investigation.
Below with reference to Fig. 6, it illustrates the computer systems 600 for the electronic equipment for being suitable for being used to realize the embodiment of the present invention
Structural schematic diagram.The computer system 600 of electronic equipment shown in Fig. 6 is only an example, should not be to the embodiment of the present invention
Function and use scope bring any restrictions.
As shown in fig. 6, computer system 600 includes central processing unit (CPU) 601, it can be read-only according to being stored in
Program in memory (ROM) 602 or be loaded into the program in random access storage device (RAM) 603 from storage section 608 and
Execute various movements appropriate and processing.In RAM 603, it is also stored with various programs and data needed for system operatio.CPU
601, ROM 602 and RAM 603 is connected with each other by bus 604.Input/output (I/O) interface 605 is also connected to bus
604。
I/O interface 605 is connected to lower component: the importation 606 including keyboard, mouse etc.；It is penetrated including such as cathode
The output par, c 607 of spool (CRT), liquid crystal display (LCD) etc. and loudspeaker etc.；Storage section 608 including hard disk etc.；
And the communications portion 609 of the network interface card including LAN card, modem etc..Communications portion 609 via such as because
The network of spy's net executes communication process.Driver 610 is also connected to I/O interface 605 as needed.Detachable media 611, such as
Disk, CD, magneto-optic disk, semiconductor memory etc. are mounted on as needed on driver 610, in order to read from thereon
Computer program be mounted into storage section 608 as needed.
Particularly, according to an embodiment of the invention, may be implemented as computer above with reference to the process of flow chart description
Software program.For example, the embodiment of the present invention includes a kind of computer program product comprising be carried on computer-readable medium
On computer program, which includes the program code for method shown in execution flow chart.In such reality
It applies in example, which can be downloaded and installed from network by communications portion 609, and/or from detachable media
611 are mounted.When the computer program is executed by central processing unit (CPU) 601, executes and limited in the system of the application
Above-mentioned function.
It should be noted that computer-readable medium shown in the present invention can be computer-readable signal media or meter
Calculation machine readable storage medium storing program for executing either the two any combination.Computer readable storage medium for example can be --- but not
Be limited to --- electricity, magnetic, optical, electromagnetic, infrared ray or semiconductor system, device or device, or any above combination.Meter
The more specific example of calculation machine readable storage medium storing program for executing can include but is not limited to: have the electrical connection, just of one or more conducting wires
Taking formula computer disk, hard disk, random access storage device (RAM), read-only memory (ROM), erasable type may be programmed read-only storage
Device (EPROM or flash memory), optical fiber, portable compact disc read-only memory (CD-ROM), light storage device, magnetic memory device,
Or above-mentioned any appropriate combination.In the present invention, computer readable storage medium can be it is any include or storage journey
The tangible medium of sequence, the program can be commanded execution system, device or device use or in connection.And at this
In invention, computer-readable signal media may include in a base band or as carrier wave a part propagate data-signal,
Wherein carry computer-readable program code.The data-signal of this propagation can take various forms, including but unlimited
In electromagnetic signal, optical signal or above-mentioned any appropriate combination.Computer-readable signal media can also be that computer can
Any computer-readable medium other than storage medium is read, which can send, propagates or transmit and be used for
By the use of instruction execution system, device or device or program in connection.Include on computer-readable medium
Program code can transmit with any suitable medium, including but not limited to: wireless, electric wire, optical cable, RF etc. are above-mentioned
Any appropriate combination.
Flow chart and block diagram in attached drawing are illustrated according to the system of various embodiments of the invention, method and computer journey
The architecture, function and operation in the cards of sequence product.In this regard, each box in flowchart or block diagram can generation
A part of one module, program segment or code of table, a part of above-mentioned module, program segment or code include one or more
Executable instruction for implementing the specified logical function.It should also be noted that in some implementations as replacements, institute in box
The function of mark can also occur in a different order than that indicated in the drawings.For example, two boxes succeedingly indicated are practical
On can be basically executed in parallel, they can also be executed in the opposite order sometimes, and this depends on the function involved.Also it wants
It is noted that the combination of each box in block diagram or flow chart and the box in block diagram or flow chart, can use and execute rule
The dedicated hardware based systems of fixed functions or operations is realized, or can use the group of specialized hardware and computer instruction
It closes to realize.
Being described in unit involved in the embodiment of the present invention can be realized by way of software, can also be by hard
The mode of part realizes that described unit also can be set in the processor.Wherein, the title of these units is in certain situation
Under do not constitute restriction to the unit itself.
As on the other hand, present invention also provides a kind of computer-readable medium, which be can be
Included in electronic equipment described in above-described embodiment；It is also possible to individualism, and without in the supplying electronic equipment.
Above-mentioned computer-readable medium carries one or more program, when the electronics is set by one for said one or multiple programs
When standby execution, so that the electronic equipment realizes such as above-mentioned block chain drug management-control method as described in the examples.
For example, the electronic equipment may be implemented as shown in Figure 1: step S101: being flowed entirely according to drug
Multiple information nodes that journey tracks construct block chain network；Step S102: based on negative sense feedback check method to the area
The potential risk of the multiple information node automatic identification drug in block chain network, obtains risk class；Step S103: if
It identifies that the drug reaches prompting rule in the risk class that any link occurs, then generates prompting message.
It should be noted that although being referred to several modules or list for acting the equipment executed in the above detailed description
Member, but this division is not enforceable.In fact, embodiment according to the present invention, it is above-described two or more
Module or the feature and function of unit can embody in a module or unit.Conversely, an above-described mould
The feature and function of block or unit can be to be embodied by multiple modules or unit with further division.
Through the above description of the embodiments, those skilled in the art is it can be readily appreciated that example described herein is implemented
Mode can also be realized by software realization in such a way that software is in conjunction with necessary hardware.Therefore, according to the present invention
The technical solution of embodiment can be embodied in the form of software products, which can store non-volatile at one
Property storage medium (can be CD-ROM, USB flash disk, mobile hard disk etc.) in or network on, including some instructions are so that a calculating
Equipment (can be personal computer, server, touch control terminal or network equipment etc.) executes embodiment according to the present invention
Method.
Those skilled in the art after considering the specification and implementing the invention disclosed here, will readily occur to of the invention its
Its embodiment.This application is intended to cover any variations, uses, or adaptations of the invention, these modifications, purposes or
Person's adaptive change follows general principle of the invention and including the undocumented common knowledge in the art of the present invention
Or conventional techniques.The description and examples are only to be considered as illustrative, and true scope and spirit of the invention are by following
Claim is pointed out.
It should be understood that the present invention is not limited to the precise structure already described above and shown in the accompanying drawings, and
And various modifications and changes may be made without departing from the scope thereof.The scope of the present invention is limited only by the attached claims.
Claims (12)
1. a kind of block chain drug management-control method characterized by comprising
Block chain network is constructed according to multiple information nodes that whole process tracks are carried out to drug；
Based on negative sense feedback check method to the latent of the multiple information node automatic identification drug in the block chain network
In risk, risk class is obtained；
If identifying that the drug reaches prompting rule in the risk class that any link occurs, prompting message is generated.
2. the method according to claim 1, wherein the data of the information node include time data, place
Data and confirmation data, the multiple information node include at least production information, transit information, check information, sales information, make
With one of information and calling information.
3. the method according to claim 1, wherein the information node is stored with linked data structure,
Building forms the block chain network；
Wherein the linked data structure includes: nomenclature of drug, drug batch number, due date, handler's public-key cryptography, access people
The public-key cryptography of member, handler's signature, the data of information node, the storage address of similar drug historical record data are linked and are mentioned
Awake information.
4. according to the method described in claim 3, it is characterized in that, being gone through to the data of the information node, the similar drug
The Records of the Historian records the storage address link of data and the prompting message is stored in the form of the link of Hash pointer.
5. the method according to claim 1, wherein the multiple information node needle in the block chain network
Subsidiary under different groups and group is set separately different access authority.
6. the method according to claim 1, wherein based on negative sense feedback check method to the block chain network
In the multiple information node automatic identification drug potential risk, obtaining risk class includes:
Virtual condition information based on the multiple information node feedback carries out that quality score is calculated；
The grade classification that potential risk is carried out according to the quality score, obtains risk class, wherein the risk class includes:
The supervision of safe, dangerous and emphasis.
7. according to the method described in claim 6, it is characterized in that, the virtual condition letter based on the multiple information node feedback
Breath carries out that quality score is calculated
The virtual condition information that the drug is fed back in each market is obtained, wherein the virtual condition information includes each
The data of a information node；
The drug is calculated in quality score locality according to the virtual condition information, wherein described is locality the pin
Sell one of ground；
Calculation formula are as follows:
Wherein YnIt is the drug in n-th of quality score locality, n is the positive integer of 1~N, and N indicates number locality,
An is the drug in n-th of sales volume locality, and m is the positive integer of 1~M, and M indicates the number of sales territory, N≤M, a
It is coefficient, X with bmVirtual condition information for the drug m-th of market.
8. according to the method described in claim 2, it is characterized in that, based on negative sense feedback check method to the block chain network
In the multiple information node automatic identification drug potential risk, obtaining risk class includes:
If being included in a certain market in the calling information of the drug has a plurality of negative complaint, the risk class is attached most importance to
Point supervision.
9. according to the method described in claim 2, it is characterized in that, based on negative sense feedback check method to the block chain network
In the multiple information node automatic identification drug potential risk, obtaining risk class includes:
If the market of the drug is in the first area, but the ground that uses in the use information for the drug is second
Area, and the spacing between first area and second area is more than preset range, then the risk class is attached most importance to
Supervision, object of supervision are bizonal drug；And/or
If the market of the drug is in the first area, but the ground that uses in the use information for the drug is multiple
Territory of use, and the multiple area is all different with first area, then the risk class is emphasis supervision, supervision pair
As the drug for the multiple territory of use.
10. a kind of block chain drug control device characterized by comprising
Network struction module, for carrying out multiple information nodes building block link network that whole process tracks according to drug
Network；
Risk identification module, for based on negative sense feedback check method to the multiple information node in the block chain network
The potential risk of automatic identification drug, obtains risk class；
Warning module, if produced for identifying that the drug reaches prompting rule in the risk class that any link occurs
Raw prompting message.
11. a kind of computer-readable medium, is stored thereon with computer program, which is characterized in that described program is held by processor
The step of block chain drug management-control method as claimed in any one of claims 1-9 wherein is realized when row.
12. a kind of electronic equipment characterized by comprising
One or more processors；
Storage device, for storing one or more programs, when one or more of programs are by one or more of processing
When device executes, so that one or more of processors realize block chain drug pipe as claimed in any one of claims 1-9 wherein
Prosecutor method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810960721.5A CN109118253A (en) | 2018-08-22 | 2018-08-22 | Block chain drug management-control method, device, medium and electronic equipment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810960721.5A CN109118253A (en) | 2018-08-22 | 2018-08-22 | Block chain drug management-control method, device, medium and electronic equipment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109118253A true CN109118253A (en) | 2019-01-01 |
Family
ID=64859983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810960721.5A Pending CN109118253A (en) | 2018-08-22 | 2018-08-22 | Block chain drug management-control method, device, medium and electronic equipment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109118253A (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109615404A (en) * | 2019-01-08 | 2019-04-12 | 广东工业大学 | Based on hard-wired block chain data encryption strengthening design |
| CN110414996A (en) * | 2019-06-26 | 2019-11-05 | 深圳壹账通智能科技有限公司 | Medicine information update method and device, electronic equipment and non-transient storage media |
| CN110704866A (en) * | 2019-09-06 | 2020-01-17 | 中国平安财产保险股份有限公司 | Block chain-based request processing method and request processing device |
| CN110766324A (en) * | 2019-10-23 | 2020-02-07 | 泰康保险集团股份有限公司 | Medicine state monitoring method, device, equipment and storage medium |
| CN111461662A (en) * | 2020-04-02 | 2020-07-28 | 北京东方金信科技有限公司 | Examination and approval system based on block chain technology |
| CN111784103A (en) * | 2020-05-22 | 2020-10-16 | 上海飞鱼医疗科技有限公司 | Reagent quality full-process management system based on block chain technology |
| CN112000068A (en) * | 2020-05-22 | 2020-11-27 | 上海飞鱼医疗科技有限公司 | Medical instrument performance quality management system based on block chain technology |
| CN112836084A (en) * | 2019-11-25 | 2021-05-25 | 北京达佳互联信息技术有限公司 | Method, device and equipment for controlling flow and storage medium |
| WO2021114406A1 (en) * | 2019-12-12 | 2021-06-17 | 深圳大学 | Blockchain-based vaccine information monitoring method and apparatus, and computer device |
| EP3958200A1 (en) * | 2020-08-21 | 2022-02-23 | Fujitsu Limited | Communication program, communication apparatus and communication method |
| CN115204914A (en) * | 2022-09-16 | 2022-10-18 | 湖南大学 | Data storage method, device, equipment and medium for drug anti-counterfeiting tracing source block chain |
| CN117035402A (en) * | 2023-07-19 | 2023-11-10 | 盐城市食品药品监督检验中心 | Drug risk management and control method and system |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107294709A (en) * | 2017-06-27 | 2017-10-24 | 阿里巴巴集团控股有限公司 | A kind of block chain data processing method, apparatus and system |
| CN108009830A (en) * | 2017-12-14 | 2018-05-08 | 上海密尔克卫化工储存有限公司 | Products in circulation tracking and system based on block chain |
| US20180189449A1 (en) * | 2017-01-04 | 2018-07-05 | International Business Machines Corporation | Tracking items used for providing medical services |
-
2018
- 2018-08-22 CN CN201810960721.5A patent/CN109118253A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180189449A1 (en) * | 2017-01-04 | 2018-07-05 | International Business Machines Corporation | Tracking items used for providing medical services |
| CN107294709A (en) * | 2017-06-27 | 2017-10-24 | 阿里巴巴集团控股有限公司 | A kind of block chain data processing method, apparatus and system |
| CN108009830A (en) * | 2017-12-14 | 2018-05-08 | 上海密尔克卫化工储存有限公司 | Products in circulation tracking and system based on block chain |
Non-Patent Citations (2)
| Title |
|---|
| 向勇: "质量风险管理在药品经营企业GSP实施中的作用", 《首都医药》 * |
| 肖丽等: "基于区块链技术的中药溯源体系研究", 《时珍国医国药》 * |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109615404A (en) * | 2019-01-08 | 2019-04-12 | 广东工业大学 | Based on hard-wired block chain data encryption strengthening design |
| CN110414996A (en) * | 2019-06-26 | 2019-11-05 | 深圳壹账通智能科技有限公司 | Medicine information update method and device, electronic equipment and non-transient storage media |
| CN110704866A (en) * | 2019-09-06 | 2020-01-17 | 中国平安财产保险股份有限公司 | Block chain-based request processing method and request processing device |
| CN110704866B (en) * | 2019-09-06 | 2024-07-09 | 中国平安财产保险股份有限公司 | Request processing method and request processing device based on block chain |
| CN110766324A (en) * | 2019-10-23 | 2020-02-07 | 泰康保险集团股份有限公司 | Medicine state monitoring method, device, equipment and storage medium |
| CN112836084B (en) * | 2019-11-25 | 2024-03-15 | 北京达佳互联信息技术有限公司 | Method, device, equipment and storage medium for controlling flow |
| CN112836084A (en) * | 2019-11-25 | 2021-05-25 | 北京达佳互联信息技术有限公司 | Method, device and equipment for controlling flow and storage medium |
| WO2021114406A1 (en) * | 2019-12-12 | 2021-06-17 | 深圳大学 | Blockchain-based vaccine information monitoring method and apparatus, and computer device |
| CN111461662A (en) * | 2020-04-02 | 2020-07-28 | 北京东方金信科技有限公司 | Examination and approval system based on block chain technology |
| CN112000068A (en) * | 2020-05-22 | 2020-11-27 | 上海飞鱼医疗科技有限公司 | Medical instrument performance quality management system based on block chain technology |
| CN111784103B (en) * | 2020-05-22 | 2024-05-07 | 上海飞鱼医疗科技有限公司 | Reagent quality whole-flow management system based on blockchain technology |
| CN111784103A (en) * | 2020-05-22 | 2020-10-16 | 上海飞鱼医疗科技有限公司 | Reagent quality full-process management system based on block chain technology |
| EP3958200A1 (en) * | 2020-08-21 | 2022-02-23 | Fujitsu Limited | Communication program, communication apparatus and communication method |
| CN115204914A (en) * | 2022-09-16 | 2022-10-18 | 湖南大学 | Data storage method, device, equipment and medium for drug anti-counterfeiting tracing source block chain |
| CN117035402A (en) * | 2023-07-19 | 2023-11-10 | 盐城市食品药品监督检验中心 | Drug risk management and control method and system |
| CN117035402B (en) * | 2023-07-19 | 2024-03-01 | 盐城市食品药品监督检验中心 | Drug risk management and control method and system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109118253A (en) | Block chain drug management-control method, device, medium and electronic equipment | |
| Hu et al. | Vaccine supply chain management: An intelligent system utilizing blockchain, IoT and machine learning | |
| Zhu et al. | A blockchain based solution for medication anti-counterfeiting and traceability | |
| Antal et al. | Blockchain platform for COVID-19 vaccine supply management | |
| Agarwal et al. | Blockchain technology for secure supply chain management: A comprehensive review | |
| US20210256070A1 (en) | Non-fungible token (nft) | |
| Sylim et al. | Blockchain technology for detecting falsified and substandard drugs in distribution: pharmaceutical supply chain intervention | |
| Kang et al. | An interactive trust model for application market of the internet of things | |
| CN109036579A (en) | Information forecasting method, device, medium and electronic equipment based on block chain | |
| US20180268418A1 (en) | Warranty enriched transactions | |
| CA2992458A1 (en) | Computationally efficient transfer processing, auditing, and search apparatuses, methods and systems | |
| Abdallah et al. | Blockchain-based solution for pharma supply chain industry | |
| CN109493047A (en) | A kind of commission settlement method, device and terminal device based on block chain | |
| US11379833B2 (en) | Systems and methods of generating, validating, approving, recording, and utilizing digital data assets in a blockchain platform using a transactional proof of work | |
| Taherdoost et al. | Blockchain-based e-commerce: A review on applications and challenges | |
| Yang et al. | Blockchain for supply chain performance and logistics management | |
| Bapatla et al. | PharmaChain: A blockchain to ensure counterfeit‐free pharmaceutical supply chain | |
| Chen et al. | A traceable and verifiable tobacco products logistics system with GPS and RFID technologies | |
| Lukić et al. | Possible blockchain solutions according to a smart city digitalization strategy | |
| Chen et al. | Blockchain-based anti-counterfeiting management system for traceable luxury products | |
| Liu et al. | A Literature Review of Blockchain-Based Applications in Supply Chain | |
| Junior et al. | Data security and trading framework for smart grids in neighborhood area networks | |
| Marbouh et al. | Blockchain for patient safety: use cases, opportunities and open challenges | |
| US11836688B1 (en) | Method and apparatus to tokenize natural resources | |
| CN109616218A (en) | Data processing method, device, medium and electronic equipment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190101 |
|
| RJ01 | Rejection of invention patent application after publication |